Literature DB >> 13791490

Site of action of hydralazine and dihydralazine in man.

B ABLAD.   

Abstract

Entities:  

Keywords:  HYDRALAZINE/pharmacology

Mesh：

Substances：

Year:  1959        PMID： 13791490

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  3 in total

1.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

2.  A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.

Authors:  P J Manhem; S G Ball; J J Morton; G D Murray; B J Leckie; R Fraser; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

3.  Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.

Authors:  M Velasco; A Urbina-Quintana; J Morillo; H Vizcarrondo; A Ramirez; E Hernández; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.